OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
29
Results
Show all
Save search
Copy query
Show results for
Unknown
(29)
Publication Date
Release Date
2021
(3)
2013
(3)
2011
(3)
2006
(3)
2025
(2)
2023
(2)
2018
(2)
2008
(2)
2024
(1)
2022
(1)
2020
(1)
2017
(1)
2014
(1)
2012
(1)
2007
(1)
2005
(1)
2000
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Not available
S-EPMC8445435
|
biostudies-literature
Cite
Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre.
Not available
S-EPMC10471726
|
biostudies-literature
Cite
High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort.
Not available
S-EPMC3718831
|
biostudies-literature
Cite
Characterisation of heritable TP53-related cancer syndrome in Sweden-a nationwide study of genotype-phenotype correlations in 90 families.
Not available
S-EPMC11986147
|
biostudies-literature
Cite
Li-Fraumeni syndrome in Tunisian carriers with different and rare tumor phenotype: genotype-phenotype correlation.
Not available
S-EPMC8895785
|
biostudies-literature
Cite
Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome.
Not available
S-EPMC12560191
|
biostudies-literature
Cite
TP53 p.Arg337His germline mutation prevalence in Southern Brazil: Further evidence for mutation testing in young breast cancer patients.
Not available
S-EPMC6312227
|
biostudies-literature
Cite
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
Not available
S-EPMC1287180
|
biostudies-literature
Cite
TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge.
Not available
S-EPMC8087555
|
biostudies-literature
Cite
A substantial proportion of apparently heterozygous TP53 pathogenic variants detected with a next-generation sequencing hereditary pan-cancer panel are acquired somatically.
Not available
S-EPMC6972517
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets